PMPRB Price Review: Navigating the New Pricing Landscape | Session Recording

Industry experts from Insight Biosciences, AbbVie, GSK, and IQVIA discuss the latest PMPRB guidelines and their potential impact on drug pricing, market access, and healthcare innovation in Canada.

Key Topics:
– PMPRB’s evolving regulatory approach
– Potential effects on drug launches and R&D investments
– Strategies for pharmaceutical manufacturers
– Balancing drug pricing and patient access

Featuring insights from:
– Lauren Fischer (AbbVie)
– Ryan Locke (GSK)
-Joan McCormick (IQVIA)